Understanding and Managing Addiction as a Chronic Condition

Slides:



Advertisements
Similar presentations
Director Peter Delany, Ph
Advertisements

Overcoming Indigenous Disadvantage in Australia Gary Banks Chairman, Productivity Commission OECD WORLD FORUM Statistics, Knowledge and Policy Measuring.
© March, In Their Own Right, 2002The Alan Guttmacher Institute (AGI) Why Worry About Men? Addressing mens sexual and reproductive health will help.
The Role of Health Coverage in Eliminating Disparities in Care Marsha Lillie-Blanton, DrPH Associate Research Professor GWU School of Public Health and.
TRI science addiction Lost Opportunity? SBI for Substance Abuse In ERs and Trauma Centers Academy Health Mady Chalk, Ph.D. Treatment Research Institute.
The Impact of Drug Benefit Caps Geoffrey Joyce, PhD.
Behavioral health disorders are common.
Figure 1. There Are 13.3 Million Uninsured Young Adults Ages 19–29, 30 Percent of the Nonelderly Uninsured, 2005 Source: Analysis of the March 2006 Current.
CLOSING THE DIVIDE: HOW MEDICAL HOMES PROMOTE EQUITY IN HEALTH CARE Results from the Commonwealth Fund 2006 Health Care Quality Survey THE COMMONWEALTH.
M. Fe Caces, Ph. D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC June 2003 Treatment.
M. Fe Caces, Ph.D. Statistician/Demographer Office of National Drug Control Policy Executive Office of the President Washington, DC Presentation for the.
Targeted Case Management - A Model in Progress Presentation to PAC October 16, 2009.
Undergraduates in Minnesota: Who are they and how do they finance their education? Tricia Grimes Shefali Mehta Minnesota Office of Higher Education November.
Behavioral Health DATA BOOK A quarterly reference to community mental health and substance abuse services Fiscal Year 2013 Quarter 1 January 9, 2012
11 Liang Y. Liu, Ph.D. Community Mental Health & Substance Abuse Services Section Texas Department of State Health Services
Behavioral Health DATA BOOK A quarterly reference to community mental health and substance abuse services Fiscal Year 2011 Quarter 4 October 10, 2011.
Fiscal Condition of the States Presentation to the Rhode Island House of Representatives Economic Forum December 1, 2009 Arturo Pérez Fiscal Affairs Program.
Briefing July 16, 2001 Judge Kathleen Kearney Kenneth A. DeCerchio Secretary Director of Substance Abuse Substance Abuse Program.
1 1  1 =.
Intervening with Adolescent Substance User: What do we know so far about and where do we go from here Michael Dennis, Ph.D. Chestnut Health Systems, Normal,
Advances in Adolescent Substance Abuse Treatment and Research Michael Dennis, Ph.D. Chestnut Health Systems, Bloomington, IL Part of the continuing education.
Recovery Oriented Systems of Care: Recovery Management Checkups (RMC) Michael Dennis, Ph.D. & Christy K Scott, Ph.D. Chestnut Health Systems, Normal &
The basics for simulations
By The Numbers: The Public Costs of Teen Childbearing
401(k) Participant Behavior in a Volatile Economy Prepared for the 14 th Annual RRC Conference, August 2, 2012 by Barbara Butrica and Karen Smith 1.
Quality of Life Presented By Childrens Services Council February 2009.
Crime, Violence, and Managing Client and Public Safety Michael L. Dennis, Ph.D., Chestnut Health Systems, Bloomington, IL Presentation at NEW DIRECTIONS.
Chapter 16 Subset of Overview by Level of Care GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from.
Effects on UK of Eustatic sea Level rise GIS is used to evaluate flood risk. Insurance companies use GIS models to assess likely impact and consequently.
AHS IV Trivia Game McCreary Centre Society
Chris Bonnett, MHSc, PhD (Cand.) H3 Consulting, Guelph Managing Chronic Disease Can it work at work?
Opportunities for Prevention & Intervention in Child Maltreatment Investigations Involving Infants in Ontario Barbara Fallon, PhD Assistant Professor Jennifer.
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
Why target YouthBuild for screening, brief intervention and treatment - or don’t you have enough to do already? Michael Dennis, Ph.D. Chestnut Health Systems,
Variation in DSM-IV Symptom Severity Depending on Type of Drug and Age: A Facets Analysis Michael L. Dennis, Ph.D. Chestnut Health Systems, Bloomington,
Using Data to Inform Practice Michael L. Dennis, Ph.D. Chestnut Health Systems, Normal IL Presentation at SAMHSA/CSAT Satellite Session, “ Implementing.
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
13 Principles of Effective Addictions Treatment
Briefing for the SAMHSA Workgroup on Underage and Problem Drinking Michael Dennis, Ph.D. Chestnut Health Systems, Normal, IL Presentation for the Substance.
16 Sobering Facts 1.Boys are more likely than girls to begin drinking before age 13.* The earlier underage drinking begins, the greater the risk for developing.
1 Managing Substance Use Disorders (SUDS) as a Chronic Condition Michael L. Dennis, Ph.D. Chestnut Health Systems 720 W. Chestnut, Bloomington, IL 61701,
Mental Health Service Needs and Service Use of Juvenile Detainees Karen Abram, Ph.D. Psycho-Legal Studies Program Northwestern University Feinberg School.
Click the arrows to advance forward and backward. Click the Next link below to advance to the assessment. The A B C & D’s of Suicide Assessment and Clinical.
Other MCH Issues and Special Populations Marsha R. Smith, M.D., M.P.H. Medical Director, Perinatal and Reproductive Health Center for Maternal and Child.
Healthy People 2010: Mental Health Objectives Substance Abuse and Mental Health Services Administration January 20, 2000.
So What Happened to All of Those 20-Something Students Who Didn’t Complete Their Degree Programs? Bruce Chaloux Southern Regional Education Board.
Addiction: What Every Judge Should Know Michael L. Dennis, Ph.D. Chestnut Health Systems Normal, IL Presentation at “Addiction: What Every Judge Should.
1 Intervening in the Recovery Process Michael L. Dennis, Ph.D. Christy K Scott, Ph.D. Chestnut Health Systems, Bloomington &Chicago, IL U.S.A. Presentation.
Chestnut Health Systems, Normal, IL
1 Characteristics, Needs, Services and Outcomes of Juvenile Treatment Drug Courts compared to Adolescent Outpatient and Adult Treatment Drug Courts Melissa.
1 Understanding and Managing The Recovery Cycle Michael L. Dennis, Ph.D. and Christy K Scott, Ph.D. Chestnut Health Systems 720 W. Chestnut, Bloomington,
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
1 Research on Understanding and Managing Addiction as a Chronic Condition Michael L. Dennis, Ph.D. Chestnut Health Systems Normal, IL Presentation at the.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Trajectories of criminal behavior among adolescent substance users during treatment and thirty-month follow-up Ya-Fen Chan, Ph.D., Rod Funk, B.S., & Michael.
Trauma Issues with Specific Populations: Adolescents & Transition Age Youth OVERVIEW Michael Dennis, Ph.D. and Megan Catlin, M.S. Chestnut Health Systems,
1 Understanding and Managing Addiction as a Chronic Condition Michael L. Dennis, Ph.D. Chestnut Health Systems Normal, IL Presentation at the Pacific Asia.
1 Findings from the Pathways to Recovery and Recovery Management Checkups (RMC) Experiments Michael L. Dennis, Ph.D. & Christy K Scott, Ph.D. Chestnut.
Substance Abuse Treatment Reduces Costs to Society; Eliminating Substance Abuse Treatment Increases Costs Michael Dennis, Ph.D.* Christy K Scott, Ph.D.**
Creating Quality Coverage to Support Sustainable Recovery Families USA 2014 Health Action Conference Mental Health and Substance Use Disorder Care in a.
Do drug-using students need to stay in school? In developing a treatment program the central question is:
Chapter 11 Subset of Overview by Mental Health Disorders GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse Research Advances in What.
Chapter 15 Subset of Overview by Program GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
Chapter 6 Subset of Overview by Gender GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
Chapter 13 Subset of Overview by Crime and Violence GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Chapter 9 Subset of Overview by Risk of Homelessness GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
Chapter 17 Subset of Overview by Type of Treatment GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available.
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
Presentation transcript:

Understanding and Managing Addiction as a Chronic Condition Michael L. Dennis, Ph.D. Chestnut Health Systems Normal, IL Presentation at the Congressional Addiction, Treatment, and Recovery Caucus Briefing, “Reducing Health Care Costs: Chronic Disease Management for Alcohol & Drug Problems,” June 11, 2009 from 1:00-3:00 p.m., 122 Cannon House Office Building. This presentation was supported by funds from and data from NIDA grants no. R01 DA15523, R37-DA11323, CSAT contract no. 270-07-0191 and several other authors/studies. It is available electronically at www.chestnut.org/li/posters. The opinions are those of the author and do not reflect official positions of the government. I would like to thank Redonna Chandler, Wilson Compton, Mark Godley, Thomas Hilton, Randy Muck, Chris Scott, and Alan Sender, for their assistance in preparing this presentation. Please address comments or questions to the author at mdennis@chestnut.org or 309-451-7801. .p Thank you… I would like to start by acknowledging that this presentation builds on a series of studies and papers the Chris Scott, and I have done… as well as data from the several large community and clinical epidemiological data bases made available to the public by the U.S. Government. Also note that i have posted an electronic copy of this presentation at www.chestnut.org/li/posters

The Goals of this Presentation are to: Illustrate the chronic nature of substance use disorders Examine the likelihood and nature of sustained recovery Demonstrate the feasibility of using simple protocols like recovery checkups to improve long-term outcomes

Normal levels of brain activity in PET scans show up in yellow to red Prolonged Substance Use Injures The Brain: Healing Takes Time Normal levels of brain activity in PET scans show up in yellow to red Normal Reduced brain activity after regular use can be seen even after 10 days of abstinence 10 days of abstinence After 100 days of abstinence, we can see brain activity “starting” to recover Slide 8: Long-term effects of drug abuse The images in these PET scans, which depict brain glucose utilization (a marker of brain activity), show that once the brain becomes addicted to a drug like cocaine, it is affected for a long, long time. In other words, once addicted, the brain is literally changed. Let’s see how.   In this slide, increasing amounts of brain function are measured by yellow or red. The top row shows a normal functioning brain without drugs. You can see a lot of brain activity. In other words, there is a lot of yellow and red color. The middle row shows a cocaine addict’s brain after 10 days without any cocaine use at all. What is happening here? [Pause for response.] Less yellow and red means less normal activity occurring in the brain—even after the cocaine abuser has abstained from the drug for 10 days. The third row shows the same addict’s brain after 100 days without any cocaine. We can see a little more yellow and red, so there is some improvement— more brain activity—at this point. But the addict’s brain is still not back to a normal level of functioning. . . more than 3 months later. Scientists are concerned that there may be areas in the brain that never fully recover from drug abuse and addiction. 100 days of abstinence Source: Volkow ND, Hitzemann R, Wang C-I, Fowler IS, Wolf AP, Dewey SL. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11:184-190, 1992; Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey 5, Wolf AP. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177, 1993.

Alcohol and Other Drug Abuse, Dependence and Problem Use Peaks at Age 20 100 People with drug dependence die an average of 22.5 years sooner than those without a diagnosis Over 90% of use and problems start between the ages of 12-20 90 Percentage 80 It takes decades before most recover or die 70 60 Severity Category 50 Other drug or heavy alcohol use in the past year 40 30 Alcohol or Drug Use (AOD) Abuse or Dependence in the past year This figure shows how the prevalence of these past year severity categories vary by age. 1- Substance use disorders typically on set during adolescents and young adult hood. In fact, 90% of all adults with dependence started using under the age of 18, half under the age of 15. 2- After several decades, the rates of abuse and dependence do decrease as people go into remission, incarceration or die. Epidemiological studies of people with lifetime substance dependence suggest that 58% eventually enter sustained recovery (i.e., no symptoms for the past year) -- a rate that is considerably better than the 39% average rate of recovery across psychiatric disorders (Kessler, 1994; see also Dawson, 1996; Robins & Regier, 1991). 3 – Notice how the rates of no use go up with age. Thus substance use disorders on set early and last for many years, but do get better over time. *2002 U.S. Household Population estimated to be 235,143,246 20 10 65+ 12-13 14-15 16-17 18-20 21-29 30-34 35-49 50-64 Age Source: 2002 NSDUH and Dennis & Scott, 2007, Neumark et al., 2000

Substance Use Disorders are Common, But Treatment Participation Rates Are Low Over 88% of adolescent and young adult treatment and over 50% of adult treatment is publicly funded Few Get Treatment: 1 in 17 adolescents, 1 in 22 young adults, 1 in 12 adults Much of the private funding is limited to 30 days or less and authorized day by day or week by week Source: OAS, 2006 – 2003, 2004, and 2005 NSDUH

People Entering Publicly Funded Treatment Generally Use For Decades It takes 27 years before half reach 1 or more years of abstinence or die 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percent still using Years from first use to 1+ years of abstinence 5 10 15 20 25 30 Source: Dennis et al., 2005

The Younger They Start, The Longer They Use Age of First Use 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percent still using Age of First Use Years from first use to 1+ years of abstinence 60% longer under 15 15-20 21+ 5 10 15 20 25 30 Source: Dennis et al., 2005

Years to first Treatment Admission The Sooner They Get The Treatment, The Quicker They Get To Abstinence Years to first Treatment Admission 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percent still using 20 or more years Years from first use to 1+ years of abstinence 57% quicker 10 to 19 years 0 to 9 years 5 10 15 20 25 30 Source: Dennis et al., 2005

After Initial Treatment… Relapse is common, particularly for those who: Are Younger Have already been to treatment multiple times Have more mental health issues or pain It takes an average of 3 to 4 treatment admissions over 9 years before half reach a year of abstinence Yet over 2/3rds do eventually abstain Treatment predicts who starts abstinence Self help engagement predicts who stays abstinent Source: Dennis et al., 2005, Scott et al 2005

The Likelihood of Sustaining Abstinence Another Year Grows Over Time After 4 years of abstinence, about 86% will make it another year After 1 to 3 years of abstinence, 2/3rds will make it another year 100% . Only a third of people with 1 to 12 months of abstinence will sustain it another year 86% 90% 80% 66% 70% 60% % Sustaining Abstinence Another Year 50% 36% 40% 30% 20% A key question that is often asked is how long someone is at risk of relapse. This figure shows the odds of sustaining relapsed from year 7 to year 8 based on the duration of abstinence. 10% 0% 1 to 12 months 1 to 3 years 4 to 7 years Duration of Abstinence But even after 7 years of abstinence, about 14% relapse each year Source: Dennis, Foss & Scott (2007)

What does recovery look like on average? Duration of Abstinence 1-12 Months 1-3 Years 4-7 Years More clean and sober friends Less illegal activity and incarceration Less homelessness, violence and victimization Less use by others at home, work, and by social peers Virtual elimination of illegal activity and illegal income Better housing and living situations Increasing employment and income More social and spiritual support Better mental health Housing and living situations continue to improve Dramatic rise in employment and income Dramatic drop in people living below the poverty line Source: Dennis, Foss & Scott (2007)

Sustained Abstinence Also Reduces The Risk of Death The Risk of Death goes down with years of sustained abstinence Users/Early Abstainers more likely to die in the next 12 months It takes 4 or more years of abstinence for risk to get down to community levels Deaths in the next 12 months - (Matched on Gender, Race & Age) Source: Scott, Dennis, Simeone & Funk (forthcoming)

Other factors related to death rates Death is more likely for those who Are older Are engaged in illegal activity Have chronic health conditions Spend a lot of time in hospitals Spend a lot of time in and out of substance abuse treatment Death is less common for those who Have a greater percent of time abstinent Have longer periods of continuous abstinence Get back to treatment sooner after relapse

Recovery Management Checkups (RMC) Quarterly monitoring after treatment Linkage meeting/motivational interviewing to: provide personalized feedback to participants about their substance use and related problems, help the participant recognize the problem and consider returning to treatment, address existing barriers to treatment, and schedule an assessment. Linkage assistance reminder calls and rescheduling Transportation and being escorted as needed Treatment Engagement Specialist

Reducing Time from Relapse to Readmission 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 50% more got back to treatment Time from relapse to readmission reduced by over 50% Percent Readmitted 1+ Times 55% Checkups 37% Control 0% 3 6 9 12 15 18 21 Months From Relapse to Readmission Source: Scott & Dennis (2009)

Positive Consequences of Early Readmission Checkups and Early Readmission to Treatment were associated with: Less substance use and problems Longer periods of abstinence More attendance and engagement in self help activities Above were associated with: Fewer HIV risk behaviours Less illegal activity, arrests, and time incarcerated Fewer mental health problems Less utilization and costs to society Source: Scott & Dennis (2009)

Cost of Substance Abuse Treatment Episode $750 per night in Detox $1,115 per night in hospital $13,000 per week in intensive care for premature baby $27,000 per robbery $67,000 per assault Drug treatment courts - Bhati et al (2008) To Treat or Not To Treat: Evidence on the Prospects of Expanding Treatment to Drug-Involved Offenders. Washington, DC: Urban Institute. Health Serv Res. 2006 February; 41(1): 192–213. doi: 10.1111/j.1475-6773.2005.00466.x.PMCID: PMC1681530Copyright © Health Research and Education Trust Benefit–Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment “Pay for Itself”? Susan L Ettner, David Huang, Elizabeth Evans, Danielle Rose Ash, Mary Hardy, Mickel Jourabchi, and Yih-Ing Hser The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement Michael T. French, (Ph.D.)a,b,c,d,⁎, Ioana Popovici, (Ph.D.)d, Lauren Tapsell, (B.A.)d Journal of Substance Abuse Treatment xx (2008) xxx–xxx $22,000 / year to incarcerate an adult $30,000/ child-year in foster care $70,000/year to keep a child in detention Source: French et al., 2008; Chandler et al., 2009; Capriccioso, 2004

Investing in Treatment has a Positive Annual Return on Investment (ROI) Substance abuse treatment has been shown to have a ROI of between $1.28 to $7.26 per dollar invested Treatment drug courts have an average ROI of $2.14 to $2.71 per dollar invested This also means that for every dollar treatment is cut, we lose more money than we saved. Drug treatment courts - Bhati et al (2008) To Treat or Not To Treat: Evidence on the Prospects of Expanding Treatment to Drug-Involved Offenders. Washington, DC: Urban Institute. Health Serv Res. 2006 February; 41(1): 192–213. doi: 10.1111/j.1475-6773.2005.00466.x.PMCID: PMC1681530Copyright © Health Research and Education Trust Benefit–Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment “Pay for Itself”? Susan L Ettner, David Huang, Elizabeth Evans, Danielle Rose Ash, Mary Hardy, Mickel Jourabchi, and Yih-Ing Hser The economic costs of substance abuse treatment: Updated estimates and cost bands for program assessment and reimbursement Michael T. French, (Ph.D.)a,b,c,d,⁎, Ioana Popovici, (Ph.D.)d, Lauren Tapsell, (B.A.)d Journal of Substance Abuse Treatment xx (2008) xxx–xxx Source: Bhati et al., (2008); Ettner et al., (2006)

Summary Points Addiction can be a chronic condition with high costs to the individual and society Getting people to recovery earlier requires getting people to treatment sooner after initial use and after relapse Simple protocols like recovery checkups can help achieve abstinence sooner and improve a wide range of outcomes

Implications for Health Care Reform Finance addiction care similar to models for other chronic conditions Fund programs to get people into treatment early Expand capacity to reduce treatment gap Increase step down and continuing care Increase links to self help and recovery services Require several years of monitoring and early re-intervention when people relapse Financing for addiction care should ideally be modeled after financing for other chronic conditions This means being more assertive in finding and getting people into treatment initially Expanded treatment capacity to reduce demand Improved step down and continuing care Better linkage to self help and recovery services Several years of post treatment monitoring Teaching self management and monitoring Assertive early re-intervention when people relapse

References Bhati et al. (2008) To Treat or Not To Treat: Evidence on the Prospects of Expanding Treatment to Drug-Involved Offenders.  Washington, DC: Urban Institute. Capriccioso, R. (2004).  Foster care: No cure for mental illness.  Connect for Kids.  Accessed on 6/3/09 from http://www.connectforkids.org/node/571 Chandler, R.K., Fletcher, B.W., Volkow, N.D. (2009).  Treating drug abuse and addiction in the criminal justice system: Improving public health and safety.  Journal American Medical Association, 301(2), 183-190 Dennis, M.L., Foss, M.A., & Scott, C.K (2007). An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Evaluation Review, 31(6), 585-612 Dennis, M. L., Scott, C. K. (2007). Managing Addiction as a Chronic Condition. Addiction Science & Clinical Practice , 4(1), 45-55. Dennis, M. L., Scott, C. K., Funk, R., & Foss, M. A. (2005). The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment, 28, S51-S62. Ettner, S.L., Huang, D., Evans, E., Ash, D.R., Hardy, M., Jourabchi, M., & Hser, Y.I. (2006).  Benefit Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment Pay for Itself?.  Health Services Research, 41(1), 192-213. French, M.T., Popovici, I., & Tapsell, L. (2008). The economic costs of substance abuse treatment: Updated estimates of cost bands for program assessment and reimbursement. Journal of Substance Abuse Treatment, 35, 462-469 Neumark, Y.D., Van Etten, M.L., & Anthony, J.C. (2000). Drug dependence and death: Survival analysis of the Baltimore ECA sample from 1981 to 1995. Substance Use and Misuse, 35, 313-327. Office of Applied Studies (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings Rockville, MD:  Substance Abuse and Mental Health Services Administration.  http://www.oas.samhsa.gov/NSDUH/2k5NSDUH/2k5results.htm#7.3.1  Riley, B.B.,, Scott, C.K, & Dennis, M.L. (2008). The effect of recovery management checkups on transitions from substance use to substance abuse treatment and from treatment to recovery.  Poster presented at the UCLA Center for Advancing Longitudinal Drug Abuse Research Annual Conference, August 13-15, 2008, Los Angles, CA.  www.caldar.org . Scott, C. K., & Dennis, M. L. (in press). Results from Two Randomized Clinical Trials evaluating the impact of Quarterly Recovery Management Checkups with Adult Chronic Substance Users. Addiction. Scott, C. K., Dennis, M. L., Simeone, R., & Funk R. (forthcoming). Predicting the likelihood of death of substance users over 9 years based on baseline risk, treatment and duration of abstinence. Chicago, IL: Chestnut Health Systems. Scott, C. K., Foss, M. A., & Dennis, M. L. (2005). Pathways in the relapse, treatment, and recovery cycle over three years. Journal of Substance Abuse Treatment, 28, S61-S70. Volkow N.D., Fowler J.S., Wang G-J., Hitzemann R., Logan J., Schlyer D., Dewey 5., Wolf A.P. (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177. Volkow, N.D., Hitzemann R., Wang C-I., Fowler I.S., Wolf A.P., Dewey S.L. (1992). Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11:184-190.